Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

MicroRNAs in blood as biomarkers for Alzheimer's disease: molecular signature for personalized therapy

2018/29/B/NZ7/02757

Keywords:

Alzheimer's disease prevention diagnostics therapy pathogenesis molecular mechanism epigenetic regulation microRNA non-invasive biomarkers biomarkers in blood tau protein BACE1 ERK1 cell cycle regulation apoptosis

Descriptors:

  • NZ7_12: Prevention of human diseases

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Instytut Biologii Doświadczalnej im. M. Nenckiego Polskiej Akademii Nauk

woj. mazowieckie

Other projects carried out by the institution 

Principal investigator (from the host institution):

prof. Urszula Wojda 

Number of co-investigators in the project: 5

Call: OPUS 15 - announced on 2018-03-15

Amount awarded: 1 130 600 PLN

Project start date (Y-m-d): 2019-01-28

Project end date (Y-m-d): 2024-07-27

Project duration:: 36 months (the same as in the proposal)

Project status: Project completed

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

  • Publication in academic press/journals (6)
  1. Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm
    Authors:
    Wioleta Grabowska-Pyrzewicz, Andrew Want, Jerzy Leszek, Urszula Wojda
    Academic press:
    EBioMedicine - part of The Lancet (rok: 2021, tom: 74, strony: 103691), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ebiom.2021.103691 - link to the publication
  2. Candidate Alzheimer's disease biomarker miR-483-5p lowers TAU phosphorylation by direct ERK1/2 repression
    Authors:
    Siranjeevi Nagaraj, Andrew Want, Katarzyna Laskowska-Kaszub, Alexandra Fesiuk, Sara Vaz, Elsa Logarinho, Urszula Wojda
    Academic press:
    International Journal of Molecular Sciences (rok: 2021, tom: 22, strony: 45309), Wydawca: MDPI
    Status:
    Published
  3. Western diet as a trigger of Alzheimer's disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration
    Authors:
    Angelika Więckowska-Gacek , Anna Mietelska-Porowska , Małgorzata Wydrych , Urszula Wojda
    Academic press:
    Ageing Research Reviews (rok: 2021, tom: 70, strony: 101397), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.arr.2021.101397 - link to the publication
  4. The Perspective of Exosomal MicroRNAs as Biomarkers for Preclinical Alzheimer's Disease
    Authors:
    Urszula Wojda
    Academic press:
    Biological Psychiatry (rok: 2022, tom: 92, strony: 45419), Wydawca: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.biopsych.2022.04.006 - link to the publication
  5. Optimized RT‑qPCR and a novel normalization method for validating circulating miRNA biomarkers in ageing‑related diseases
    Authors:
    Want A, Staniak K, Grabowska-Pyrzewicz W, Fesiuk A, Barczak A, Gabryelewicz T, Kulczyńska-Przybik A, Mroczko B, Wojda U
    Academic press:
    Scientific Reports (rok: 2023, tom: 13, strony: 20869), Wydawca: Springer Nature
    Status:
    Published
    DOI:
    10.1038/s41598-023-47971-3 - link to the publication
  6. miR-483-5p orchestrates the initiation of protein synthesis by facilitating the decrease in phosphorylated Ser209eIF4E and 4E-BP1 levels.
    Authors:
    S Nagaraj, A Stankiewicz-Drogon, E Darzynkiewicz, U Wojda*(corresponding author), R Grzela*
    Academic press:
    Scientific Reports (rok: 2024, tom: 14, strony: 4237), Wydawca: Springer Nature
    Status:
    Published
    DOI:
    10.1038/s41598-024-54154-1 - link to the publication